参考文献

[1]付改发,雷光焰,赵竹莲,等.125I新型粒子永久植入治疗恶性肿瘤的应用与观察.现代肿瘤医学, 2004;12(2):108～109.
[2]Ling CC.Permanent implants using Au-198,Pd-103 and I-125:radiobiological considerations based on the linear quadratic model.Int J Radiat Oncol Biol Phys, 1992;23(1):81～87.
[3]Raben A,Mychalczak B.Brachytherapy for non-small cell lung cancer and selected neoplasms of the chest.Chest 1997;112 (4Suppl):276S～286S
[4]刘伟琪,裴永法,任礼华,等.碘-125籽源组织间照射患者和周围人员受照剂量的测量和估算.中国辐射卫生, 2001;10(4):196-197.
[5]Chen QS, Blair HF Thyroid uptake of 125iodine after prostate perminant brachytherapy.J Urol, 2004;172(5 Pt 1):1827～1829.
[6]Grimm PD, Blasko JC, Sylvester JE, et al.10-year biochemical(prostate-specific antigen) control of prostate cancer with (125)Ibrachytherapy. Int J Radiat Oncol Biol Phys, 2001;51(1):31～40
[7]Stone NN, Stock RG, Unger P. Intermediate term biochemical-free progression and local control following 125 iodine brachytherapy for prostate cancer. J Urol, 2005;173(3):803～807.
[8]吕大鹏,李力军.术中粒子植入在进展期胰腺癌治疗中的应用.中国实用外科杂志,2004;24(5):269～270
[9]Rostomily RC, Halligan J, Geyer R, et al Permanent low-activity (125)I seed placement for the treatment of pediatric brain tumors:Preliminary experience.Pediatr Neurosurg,? 2001;34(4):198～205
[10]Chen A,Galloway M,Landreneau R, et al .Intraoperative 125I brachytherapy for high-risk stage Ⅰ non-small cell lung carcinoma.Int J Radiat Oncol Biol Phys ,1999;44(5):1057～1063.